Related Experiment Video
Updated: Jun 14, 2026
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion
Michele W L Teng1, Jeremy B Swann, Bianca von Scheidt
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
Abstract:
Several reports have shown that prophylactic depletion of regulatory T cells (Treg) using various monoclonal antibodies (mAb) in mice can stimulate potent antitumor immune responses and prevent tumor development. These same depletion methods do not significantly suppress tumor growth in a therapeutic setting. Although different strategies to deplete FoxP3(+) Treg have been used, no study has systematically compared these qualitatively for the effector mechanisms they each liberate. Herein, using prophylactic depletion of FoxP3(+) Tregs with either anti-CD4, anti-CD25, or anti-FR4 mAbs, we have compared the cellular and effector requirements for elimination of the renal carcinoma RENCA and prevention of methylcholanthrene-induced fibrosarcoma. Collectively from these two models, it was clear that CD8(+) T cells and natural killer cells played an important role downstream of Treg depletion. However, whereas all three mAbs quantitatively depleted FoxP3(+) T cells to a similar extent, subtle differences in the downstream mechanisms of tumor control existed for all three approaches. In general, neutralization of any lymphocyte subset or effector mechanism was insufficient to alter tumor suppression initiated by Treg depletion, and in some settings, the neutralization of multiple effector mechanisms failed to prevent tumor rejection. These studies reveal that Tregs control multiple redundant elements of the immune effector response capable of inhibiting tumor initiation and underscore the importance of effectively targeting these cells in any cancer immunotherapy.
Insights
Depleting regulatory T cells (Tregs) prophylactically boosts antitumor immunity. Different antibodies achieve similar Treg depletion but reveal distinct downstream mechanisms for tumor control, highlighting Tregs
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Prophylactic depletion of regulatory T cells (Tregs) using monoclonal antibodies (mAbs) can stimulate antitumor immune responses.
- Therapeutic Treg depletion has shown limited efficacy in suppressing tumor growth.
- Existing studies lack systematic comparisons of different Treg depletion strategies and their effector mechanisms.
Purpose of the Study:
- To systematically compare the cellular and effector mechanisms downstream of prophylactic Treg depletion using anti-CD4, anti-CD25, and anti-FR4 mAbs.
- To investigate the role of CD8+ T cells and natural killer cells in Treg depletion-mediated tumor control.
- To assess the impact of neutralizing specific immune subsets or effector mechanisms on Treg depletion-initiated tumor suppression.
Main Methods:
- Prophylactic depletion of FoxP3(+) Tregs in mice using anti-CD4, anti-CD25, or anti-FR4 mAbs.
- Evaluation of tumor elimination in RENCA renal carcinoma and prevention of methylcholanthrene-induced fibrosarcoma models.
- Comparison of quantitative Treg depletion and analysis of downstream effector mechanisms.
Main Results:
- All three mAbs quantitatively depleted FoxP3(+) T cells similarly.
- CD8+ T cells and natural killer cells were crucial downstream effectors of Treg depletion.
- Subtle differences in tumor control mechanisms were observed among the three mAb approaches.
- Neutralization of single or multiple immune components did not prevent Treg depletion-induced tumor rejection.
Conclusions:
- Tregs utilize multiple redundant immune effector pathways to inhibit tumor initiation.
- Effective targeting of Tregs is crucial for cancer immunotherapy.
- Understanding the distinct mechanisms of different Treg depletion strategies can optimize therapeutic approaches.
Related Concept Videos
01:27Tumor Immunotherapy
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:40Cell-mediated Immune Responses